Nephros (NEPH) Amortization of Deferred Charges (2021 - 2025)
Nephros has reported Amortization of Deferred Charges over the past 8 years, most recently at $19000.0 for Q4 2025.
- Quarterly results put Amortization of Deferred Charges at $19000.0 for Q4 2025, down 17.39% from a year ago — trailing twelve months through Dec 2025 was $84000.0 (down 7.69% YoY), and the annual figure for FY2025 was $84000.0, down 7.69%.
- Amortization of Deferred Charges for Q4 2025 was $19000.0 at Nephros, down from $22000.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for NEPH hit a ceiling of $75000.0 in Q1 2022 and a floor of $19000.0 in Q4 2025.
- Median Amortization of Deferred Charges over the past 5 years was $42500.0 (2022), compared with a mean of $40444.4.
- Biggest five-year swings in Amortization of Deferred Charges: soared 54.35% in 2022 and later crashed 54.35% in 2024.
- Nephros' Amortization of Deferred Charges stood at $74000.0 in 2021, then plummeted by 40.54% to $44000.0 in 2022, then dropped by 6.82% to $41000.0 in 2023, then tumbled by 43.9% to $23000.0 in 2024, then dropped by 17.39% to $19000.0 in 2025.
- The last three reported values for Amortization of Deferred Charges were $19000.0 (Q4 2025), $22000.0 (Q3 2025), and $20000.0 (Q2 2025) per Business Quant data.